Tamoxifen inhibits the release of arachidonic acid stimulated by thapsigargin in estrogen receptor-negative A549 cells
Jamie D. Croxtall(William Harvey Research Institute), Rod Flower(Queen Mary University of London), J.O. White(Hammersmith Hospital), Qam Choudhury(Queen Mary University of London)
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
November 1, 1997
Cited by 13
Related Papers
The development of COX2 inhibitors
|Nature Reviews Drug Discovery|2003|464
Lipocortin-1: cellular mechanisms and clinical relevance
|Trends in Pharmacological Sciences|1994|380
Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism
|British Journal of Pharmacology|2000|330
A novel role for phospholipase A <sub>2</sub> isoforms in the checkpoint control of acute inflammation
|The FASEB Journal|2004|173
Different glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells
|British Journal of Pharmacology|2002|146